Hims & Hers to launch an AI agent focused on the weight-loss journey amid strategic shifts related to GLP-1s

Hims & Hers is betting on artificial intelligence to help steer the company through its next phase of growth as it navigates shifts in drug availability, especially amid the GLP-1 boom. During its first-quarter earnings call on Monday, the telehealth company brought on its chief technology officer, Mo Elshenawy, to talk up the company’s AI investments. Overall, Hims & Hers’ AI strategy is centered on using AI to build a technology platform that can handle a variety of patient conditions, as well as shifts in the issues or medications most top-of-mind for people at any given time. Continue reading this article on modernretail.co. Sign up for Modern Retail newsletters to get the latest on the shifting dynamics between retail’s old and new guards.